Management of Pituitary Macroadenomas – Evidence‑Based Recommendations

Diagnostic Work‑Up

Pituitary adenomas present with three distinct clinical patterns: hormone hypersecretion syndromes, mass effect symptoms from tumor compression, or hypopituitarism from destruction of normal pituitary tissue, as noted by the American Association of Neurological Surgeons and the Endocrine Society 6, 7

The Endocrine Society recommends that children and adolescents with delayed or arrested puberty, growth failure, or other signs of hypopituitarism be evaluated for pituitary adenomas, with a potential diagnosis of gonadotropin deficiency or growth hormone deficiency 7, 8

Bitemporal hemianopsia (loss of peripheral vision) from optic chiasm compression is a characteristic finding in patients with macroadenomas, according to the American Association of Neurological Surgeons 6, 7
Progressive visual acuity loss can occur if left untreated, emphasizing the need for prompt medical attention, as advised by the Endocrine Society 7, 9
Visual deterioration in children and adolescents is an urgent indication for surgical decompression, as recommended by the Pediatric Endocrine Society 7, 8

The Endocrine Society notes that adrenal insufficiency is a critical pitfall that can be life-threatening if unrecognized perioperatively, highlighting the importance of assessing for hypopituitarism before surgery 7
Growth hormone deficiency in children can lead to growth failure and short stature, while in adults, it can cause decreased energy, reduced muscle mass, and increased body fat, as reported by the American Association of Clinical Endocrinologists 7, 8

Pituitary apoplexy is a medical emergency characterized by sudden severe headache, visual loss, and altered consciousness, requiring urgent neurosurgical evaluation, as emphasized by the American Association of Neurological Surgeons 7, 8
Nonfunctioning adenomas often present with mass effect symptoms, and the American Association of Neurological Surgeons recommends transsphenoidal surgery as the primary treatment for these tumors 6, 7

The Endocrine Society recommends dopamine agonists as first-line treatment for prolactinomas, with cabergoline preferred over bromocriptine due to better efficacy and tolerability 10
Transsphenoidal surgery is the first-line treatment for all pituitary adenomas except prolactinomas, as recommended by the American Association of Neurological Surgeons 10
Radiation therapy is reserved for residual or recurrent tumor after surgery, or for patients who are not surgical candidates, as noted by the American Association of Neurological Surgeons 6, 11

The Endocrine Society advises that serum βHCG and AFP should always be measured in adolescents with suspected pituitary masses to distinguish between pituitary adenomas and intracranial germ-cell tumors 8
The American Association of Clinical Endocrinologists recommends testing for macroprolactin in asymptomatic patients with elevated prolactin to avoid unnecessary treatment 10
Genetic testing is mandatory in all children and adolescents with pituitary adenomas due to the high prevalence of familial syndromes, as emphasized by the Pediatric Endocrine Society and the Endocrine Society 7, 10, 12